Skip to main content

Table 1 Demographic and clinical characteristics of European American Diabetes Heart Study (DHS) participants

From: Glomerular filtration rate and albuminuria predict mortality independently from coronary artery calcified plaque in the Diabetes Heart Study

  Mean ± SD or % Median (range)
Demographic information
Age (years) 62.0 ± 9.3 62.6 (35–86)
Gender (% female) 53.3%  
Type 2 diabetes affected (%) 83.7%  
Diabetes duration (years) 10.4 ± 7.2 8 (0–46)
% smoking (current or past) 58.7%  
Self-reported history of prior CVD (%) 39.0%  
Deceased (%) 20.9%  
Deceased from CVD (%) 9.0%  
Body composition
Height (cm) 168.6 ± 9.7 168.4 (122.8–202.0)
Weight (kg) 90.6 ± 20.2 88.3 (40.0–209.2)
BMI (kg/m2) 31.8 ± 6.5 30.8 (16.6–58.0)
Medications
Lipid lowering (%) 44.7%  
ACR/ARB (%) 44.7%  
Blood pressure
Systolic BP (mmHg) 139 ± 19 138 (70–260)
Diastolic BP (mmHg) 73 ± 10 73 (37–106)
Hypertension (%) 84.9%  
Blood biochemistry
Glucose (mg/dL) 139.3 ± 55.3 126 (16–463)
Hemoglobin A1C (%) 7.3 ± 1.7 6.9 (3.5–18.3)
Total cholesterol (mg/ dL) 186.8 ± 42.3 183 (65–427)
HDL-cholesterol (mg/dL) 43.1 ± 12.4 41 (8–104)
LDL-cholesterol (mg/dL) 105.2 ± 32.6 103 (12–236)
Triglycerides (mg/dL) 200.9 ± 131.6 172 (30–1310)
Albumin (g/dL) 4.2 ± 0.3 4.2 (3.2–5.3)
Kidney function
Serum creatinine (mg/dL) 1.08 ± 0.25 1.10 (0.40–1.75)
Estimate glomerular filtration rate (mL/min/1.73m2) 67.1 ± 20.2 64.3 (20.0–179.9)
Urine albumin/creatinine ratio (mg/g) 91.1 ± 319.9 12.4 (0.5–4165.0)
Vascular imaging
Coronary artery calcified plaque (Agatston units) 1657 ± 3148 330 (0–50415)